Minu Samanta

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Limited antitumor activity of combined BET and MEK inhibition in neuroblastoma”.

Limited antitumor activity of combined BET and MEK inhibition in neuroblastoma

Pediatric Blood & Cancer(2020)10.1002/pbc.28267

N/A

0.925DataRank · unranked

21 citations

Lori S. Hart, Alexander L. Shazad, Maria Gagliardi, Matthew Tsang, Jimmy Elias +11 more

Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma

Communications Biology(2022)10.1038/s42003-022-04209-8

N/A

0.489DataRank · unranked

25 citations

Minu Samanta, Paul Martorano, Hwan Lee, Sarah B. Gitto, Khushbu Patel +18 more

BARD1germline variants induce haploinsufficiency and DNA repair defects in neuroblastoma

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad182

N/A

0DataRank · unranked

25 citations

Laura E. Egolf, Zalman Vaksman, Minu Samanta, Matthew Tsang, David Groff +8 more

BARD1 germline variants induce haploinsufficiency and DNA repair defects in neuroblastoma

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.01.31.525066

N/A

0DataRank · unranked

3 citations

Laura E. Egolf, Zalman Vaksman, Minu Samanta, Matthew Tsang, David Groff +8 more

Data from Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma

(2023)10.1158/1078-0432.c.6532614.v1

N/A

0DataRank · unranked

0 citations

Minu Samanta, Mehran Makvandi, David Groff, Paul Martorano, Jimmy Elias +11 more

Reprogramming the neuroblastoma tumor immune microenvironment to enhance GPC2 CAR T cells

Molecular Therapy(2025)10.1016/j.ymthe.2025.05.025

N/A

0DataRank · unranked

11 citations

Sydney L. Roth, Stephanie Matlaga, Evan Cresswell-Clay, Pamela Mishra, Patrick M. Schürch +14 more

Defining the Functional Role and Potential as an Immunotherapeutic Target of ALCAM in Neuroblastoma

Molecular Cancer Therapeutics(2025)10.1158/1535-7163.mct-25-0136

N/A

0DataRank · unranked

0 citations

Jonathan Gaither, David Groff, Minu Samanta, Rebecca S. Kaufman, Liron D. Grossmann +6 more

Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-0400

N/A

0DataRank · unranked

31 citations

Minu Samanta, Mehran Makvandi, David Groff, Paul Martorano, Jimmy Elias +11 more